M S Artenstein. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Carrier State/prevention & controlDrug Resistance, MicrobialHumansMeningococcal Infections/prevention & controlNeisseria meningitidis/drug effectsNeisseria meningitidis/isolation & purificationPharynx/microbiologyRifampin/pharmacologyRifampin/therapeutic use
Substances： See more » Rifampin
Year: 1969 PMID： 4980026 DOI： 10.1056/nejm196909182811210
Source DB: PubMed Journal: N Engl J Med ISSN： 0028-4793 Impact factor: 91.245